Gut metagenomes of type 2 diabetic patients have characteristic single-nucleotide polymorphism distribution in Bacteroides coprocola

• Published in: Microbiome Vol. 5; no. 1; p. 15
• Main Authors: Chen, Yaowen, Li, Zongcheng, Hu, Shuofeng, Zhang, Jian, Wu, Jiaqi, Shao, Ningsheng, Bo, Xiaochen, Ni, Ming, Ying, Xiaomin
• Format: Journal Article
• Language: English
• Published: England BioMed Central 01.02.2017
• Subjects: alpha-Glucosidases - genetics; Bacteroides - genetics; Diabetes Mellitus, Type 2; Gastrointestinal Microbiome - genetics; Gastrointestinal Tract - microbiology; Humans; Hydrolases - genetics; Letter to the Editor; Metagenomics - methods; Polymorphism, Single Nucleotide - genetics; Phylogenetic analysis; Type 2 diabetes; Bacteria; Metagenome; SNP enrichment
• ISSN: 2049-2618; 2049-2618
• DOI: 10.1186/s40168-017-0232-3

Gut microbes play a critical role in human health and disease, and researchers have begun to characterize their genomes, the so-called gut metagenome. Thus far, metagenomics studies have focused on genus- or species-level composition and microbial gene sets, while strain-level composition and single-nucleotide polymorphism (SNP) have been overlooked. The gut metagenomes of type 2 diabetes (T2D) patients have been found to be enriched with butyrate-producing bacteria and sulfate reduction functions. However, it is not known whether the gut metagenomes of T2D patients have characteristic strain patterns or SNP distributions. We downloaded public gut metagenome datasets from 170 T2D patients and 174 healthy controls and performed a systematic comparative analysis of their metagenome SNPs. We found that Bacteroides coprocola, whose relative abundance did not differ between the groups, had a characteristic distribution of SNPs in the T2D patient group. We identified 65 genes, all in B. coprocola, that had remarkably different enrichment of SNPs. The first and sixth ranked genes encode glycosyl hydrolases (GenBank accession EDU99824.1 and EDV02301.1). Interestingly, alpha-glucosidase, which is also a glycosyl hydrolase located in the intestine, is an important drug target of T2D. These results suggest that different strains of B. coprocola may have different roles in human gut and a specific set of B. coprocola strains are correlated with T2D.